Minodronic acid

CAS No. 180064-38-4

Minodronic acid( —— )

Catalog No. M37531 CAS No. 180064-38-4

Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 Get Quote
25MG 59 Get Quote
50MG 86 Get Quote
100MG 116 Get Quote
500MG 293 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Minodronic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
  • Description
    Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    P2X Receptor
  • Recptor
    P2X Receptor | Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    180064-38-4
  • Formula Weight
    322.15
  • Molecular Formula
    C9H12N2O7P2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 5 mg/mL (15.52 mM) DMSO : < 1 mg/mL (insoluble or slightly soluble)
  • SMILES
    OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sato K, et al. A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer. 2006 Nov 20;95(10):1354-61.?
molnova catalog
related products
  • GSK-1482160

    GSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity.

  • Lu AF27139

    Lu AF27139 is an effective and selective antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 can be used in CNS diseases studies.

  • JNJ-54175446

    JNJ-54175446 (JNJ-5446) is a CNS-permeable and selective P2X7 receptor antagonist that attenuates the release of IL-1β/IL-18 from microglia, and may be used in the study of depression.